Search

for
Search:

GlossaryMonoclonal Antibodies (mAbs)

laboratory-produced molecules that target specific cells or proteins

Monoclonal antibodies (mAbs) are laboratory-produced molecules engineered to serve as substitute antibodies that can restore, enhance, or mimic the immune system's attack on cells. They are designed to bind to specific targets, such as proteins on the surface of cancer cells, making them useful in treating various diseases, including some types of cancer, autoimmune disorders, and infectious diseases.

Related Terms

Learn

0 / 0 results

— no results

Research

5 / 103 results

research Use of Calcitonin Gene-Related Peptide Monoclonal Antibodies in Patients With Rosacea: An Exploratory Comparative Case Series

April 2023 in “Journal of Investigative Dermatology”

CGRP MAbs treatment for migraines may also improve rosacea symptoms, but more research is needed to confirm its effectiveness and safety.

research Generation of Pax1/PAX1-Specific Monoclonal Antibodies

10 citations , October 2016 in “Monoclonal antibodies in immunodiagnosis and immunotherapy”

Researchers created specific antibodies that detect a protein important in development and various conditions, and can be used for research and diagnosis.

research Four Murine Monoclonal Antibodies Specific for the Inner Root Sheath in the Human Hair Follicle

1 citations , January 1989

Four antibodies were developed to help study hair follicle cell differentiation.

research Diagnosis and Treatment of Cutaneous Adverse Effects of Targeted Therapy, Antibody-Drug Conjugates, and Immunotherapy in Cancer Patients: A National Consensus Statement by the Spanish Society of Medical Oncology and the Spanish Academy of Dermatology and Venereology

January 2026 in “Clinical & Translational Oncology”

Early intervention and tailored management are crucial for skin side effects in cancer treatments.

research Patterns of Desmocollin Synthesis in Human Epithelia: Immunolocalization of Desmocollins 1 and 3 in Special Epithelia and Cultured Cells

96 citations , September 1996 in “PubMed”

Desmocollin 1 and 3 have distinct patterns in human tissues, with Dsc1 in specific skin and hair layers and Dsc3 in various epithelial layers.

View more "mabs" in research →

Community Join

3 / 3 results

community Somebody has gotta try this- HMI-115 reference anti-body

in Treatment 14 upvotes 2 years ago

The potential of using a specific antibody, HMI-115, as a treatment for hair loss alongside traditional treatments such as minoxidil and finasteride. The user suggests trying either a 240 mg or 30 mg dose to see if it works.

community The likely cost of HMI-115, when it comes out

in Technology 13 upvotes 3 years ago

A new potential hair loss treatment called HMI-115, and the cost of this treatment which may be expensive due to production costs but could be competitive with other treatments such as hair transplants.

community An argument for why we should take topical Dutasteride seriously

in Research/Science 86 upvotes 4 years ago

Topical Dutasteride may halt hair loss and effectively treat androgenic alopecia. Combining low-dose oral Dutasteride with topical application could maximize regrowth and minimize side effects.